BC Platforms is a global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice.
BC Platforms operates the Global Data Partner Network BCRQUEST.com, which provides access and analytics on genomic and clinical cohort data for drug developers, currently providing access to over 33+ M subjects across five continents.
Our technology drives the infinite loop between personalized care and research discoveries, leveraging latest science, deep technical expertise, strategic partnerships, and harmonized, diverse data collections.
Our high performing platforms enable high throughput genomic data production, flexible data integration, secure data management, efficient analysis and interpretation of molecular and clinical information.
Founded in 1997 from an MIT Whitehead project spinoff, the Company has a strong scientific heritage underpinned by over 20 years of working in close collaboration with a network of leading researchers, developers, manufacturers and vendors. BC Platforms has global operations with its headquarters in Zurich, Switzerland, research and development in Espoo, Finland, and presence in London, Boston and Singapore.
For more information, please visit www.bcplatforms.com.
BC Platforms operates the Global Data Partner Network BCRQUEST.com, which provides access and analytics on genomic and clinical cohort data for drug developers, currently providing access to over 33+ M subjects across five continents.
Our technology drives the infinite loop between personalized care and research discoveries, leveraging latest science, deep technical expertise, strategic partnerships, and harmonized, diverse data collections.
Our high performing platforms enable high throughput genomic data production, flexible data integration, secure data management, efficient analysis and interpretation of molecular and clinical information.
Founded in 1997 from an MIT Whitehead project spinoff, the Company has a strong scientific heritage underpinned by over 20 years of working in close collaboration with a network of leading researchers, developers, manufacturers and vendors. BC Platforms has global operations with its headquarters in Zurich, Switzerland, research and development in Espoo, Finland, and presence in London, Boston and Singapore.
For more information, please visit www.bcplatforms.com.
Location: Switzerland, Zurich
Employees: 51-200
Total raised: $35M
Founded date: 1997
Investors 4
| Date | Name | Website |
| - | Debiopharm | debiopharm... |
| - | Boston Mil... | bostonmill... |
| - | Tesi | tesi.fi |
| - | StartAngel... | startangel... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.11.2022 | - | $20M | - |
| 18.12.2019 | Series C | $15M | - |
Mentions in press and media 14
| Date | Title | Description |
| 15.04.2024 | PRiME-R Promote data-driven next-generation medical research with a platform that allows secure distribution and utilization of medical data | PRiME-R Promoting data-driven next-generation medical research through a platform that allows secure distribution and utilization of medical data ～NTT Life Sciences Corporation launches Japan Precision Medicine PlatformTM～ …… BC Platforms A... |
| 07.12.2023 | BC Platforms Acquires Medexprim | BC Platforms, a Zurich, Switzerland-based company which specializes in healthcare data management and analytics, acquired Medexprim, a Paris, and Toulouse, France-based real-world data company. The amount of the deal was not disclosed. The ... |
| 09.11.2022 | BC Platforms Announces Powerful Patient Data Sharing Platform to Speed up Biotech R&D Process | BC Platforms (BCP), a global leader in healthcare data management and analytics, announced it has launched a new software solution called the ‘Trusted Collaboration Environment’ (TCE) to support drug discovery for a wide range of disorders ... |
| 08.11.2022 | BC Platforms Announces USD 20 Million Growth Financing led by Jolt Capital | Investment to Underpin Position as Europe’s Leading Real World Data Provider and Enabler of Personalized Precision Medicine BC Platforms (BCP), a global leader in healthcare data management and analytics, announced it has closed a CHF 20 mi... |
| 08.11.2022 | BC Platforms Raises USD20M in Growth Financing | BC Platforms, a Zurich, Switzerland-based provider of healthcare data management and analytics solutions, raised $20M in Growth financing. The round was led by Jolt Capital. The company intends to use the funds to accelerate the expansion o... |
| 20.07.2020 | Democratising Biodata Analytics with BigOmics | |
| 20.07.2020 | Democratising Biodata Analytics with BigOmics | BigOmics Analytics was founded in 2018 – almost a year after winning third prize at the StartCup Ticino challenge – as a spin-off of the Institute of Oncology Research (affiliated to the USI Faculty of Biomedical Sciences), and is currently... |
| 18.12.2019 | BC Platforms Raises $15M in Series C Funding | BC Platforms, a Zurich, Switzerland-based genomic data management and analytics company, closed a USD $15m financing round. The round was led by IQVIA (NYSE: IQV) in conjunction with Debiopharm Innovation Fund and Tesi. As part of its inves... |
| 18.12.2019 | Zurich-based BC Platforms raises $15 million Series C to extend data analytics in genomics | BC Platforms, the Zurich-based company in genomic data management and analytics, has announced a $15 million Series C round and a new commercial collaboration with IQVIA. The round was led by IQVIA along with Debiopharm Innovation Fund and ... |
| 10.05.2017 | Term Sheet — Wednesday, May 10 | POLITE AND HOSPITABLE New money: Obvious Ventures has officially closed its second fund with $191,919,191 million in commitments. (A filing from last month revealed a first close.) The firm’s first fund featured a numeric joke – it had $123... |
Show more